VJHemOnc is committed to improving our service to you

EHA 2019 | Long-term monitoring, adherence & endpoints in CML

VJHemOnc is committed to improving our service to you

Gianantonio Rosti

Gianantonio Rosti, MD, Institute of Hematology ‘Seragnoli’, Bologna, Italy, discusses the importance of long-term monitoring and adherence in chronic myeloid leukemia (CML). This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter